Viemed Healthcare (VMD) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn | -90.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.00 |
| Dec 31, 2025 | 12.00 |
| Sep 30, 2025 | -234.00 |
| Jun 30, 2025 | 379.00 |
| Mar 31, 2025 | 200.00 |
| Dec 31, 2024 | 38.00 |
| Sep 30, 2024 | 90.00 |
| Jun 30, 2024 | -298.00 |
| Mar 31, 2024 | -91.00 |
| Dec 31, 2023 | 45.00 |
| Sep 30, 2023 | 436.00 |
| Jun 30, 2023 | 289.00 |
| Mar 31, 2023 | -267.00 |
| Dec 31, 2022 | -626.00 |
| Sep 30, 2022 | -662.00 |
| Jun 30, 2022 | -610.00 |
| Mar 31, 2022 | 263.00 |
| Dec 31, 2021 | -92.00 |
| Sep 30, 2021 | -95.00 |
| Jun 30, 2021 | -1,953.00 |
| Mar 31, 2021 | -1,347.00 |
| Dec 31, 2020 | 533.00 |
| Sep 30, 2020 | -246.00 |
| Jun 30, 2020 | 2,315.00 |
| Mar 31, 2020 | 704.00 |
| Dec 31, 2019 | -545.00 |
| Sep 30, 2019 | 94.00 |
| Jun 30, 2019 | -715.00 |
| Mar 31, 2019 | -435.00 |